RPGLIFENSERPG Life Sciences Limited· PharmaceuticalsHighPositive
Announced Sat, 14 Jun · 16:00 IST

The Board of Directors at its meeting held on Monday, April 28, 2025, had recommended a final dividend of Rs.20 and additionally a special dividend of Rs.4, aggregating to Rs.24 per Equity share of Rs.8 each of the Company for the financial year ended March 31, 2025, for approval by the shareholders at the Eighteenth Annual General Meeting ( AGM ) scheduled to be held on Wednesday, July 16, 2025, at 3.00 p.m. (IST) through Video Conferencing (VC)/ Other Audio- Visual Means (OAVM). Other relevant details are being provided in the Notice of AGM, which will be issued in due course of time.Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has fixed Friday, June 27, 2025, as the Record Date for determining entitlement of Members to receive the aforesaid dividend, if approved by the shareholders at the AGM.

Dividend Yield Above 3pctCorporate Actions View source PDF

RPGLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

RPG Life Sciences' Board has recommended a total dividend of Rs. 24 per equity share for FY 2024-25, which includes a final dividend of Rs. 20 and a one-time special dividend of Rs. 4. This is on shares with a face value of Rs. 8 each, effectively a 300% payout on face value. The 18th Annual General Meeting is scheduled for July 16, 2025, where shareholders will approve the dividend. The company has fixed June 27, 2025 as the record date to identify eligible shareholders. If approved, the dividend will be paid within 30 days of the AGM to members on record as of that date.

Likely market impact

Investors holding shares before the June 27, 2025 record date will be entitled to the Rs. 24 per share dividend. The strong payout signals healthy cash generation and shareholder-friendly intent, which should support the stock price heading into the ex-date.